These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24055412)

  • 41. Alarmed or unalarmed!! Donor red cell lysis during plateletpheresis procedure.
    Kaur D; Kandwal M
    Transfus Apher Sci; 2018 Apr; 57(2):277-280. PubMed ID: 29610044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Periodic acid-Schiff (PAS) staining of immature platelets in donors.
    Pogorelov VM; Beskorovainova VJ; Chanieva MI; Dyagileva OA; Naumova IN; Skedina MA
    Platelets; 2012; 23(1):51-9. PubMed ID: 21736421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regular plateletpheresis increased basal concentrations of soluble P-selectin in healthy donors: Possible involvement of endothelial cell activation?
    Chen Y; Lin Y; Lin H; Xiao J; Jiang L; Chen C; Zhuo X; Huang W; Zeng J; Dettke M
    Clin Chim Acta; 2016 Jul; 458():18-22. PubMed ID: 27108199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet apheresis affects prothrombin time and fibrinogen and plasminogen levels in healthy donors.
    Beyan C; Kaptan K; Ifran A
    Transfus Apher Sci; 2008 Apr; 38(2):175-6. PubMed ID: 18337171
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes in hemostasis in blood donors on the Fenwal CS 3000 separator].
    Pittrová H; Koza V; Cepelák V; Vít L
    Vnitr Lek; 1990 Dec; 36(12):1197-202. PubMed ID: 2284719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Statistical analysis of parameters which determine yield in continuous centrifugal plateletpheresis].
    Hühn A; Sachs V; Dörner R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):277-81. PubMed ID: 2475408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood clotting activation and the effect of dilution during plateletpheresis.
    Parco S; Cerneca F; Simeone R; Radillo O; Mangiarotti M
    Int J Artif Organs; 1994 Sep; 17(9):508. PubMed ID: 7890440
    [No Abstract]   [Full Text] [Related]  

  • 49. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Serum ferritin in donors with regular plateletpheresis].
    Ma CH; Guo RH; Wu WJ; Yan JX; Yu JL; Zhu YH; He QT; Luo YH; Huang L; Ye RY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):508-10. PubMed ID: 21518519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety.
    Gupta AM; Bajpai M
    J Clin Apher; 2020 Jan; 35(1):18-24. PubMed ID: 31663633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Demographic, laboratory, and operational variables that influence short- and long-term plateletpheresis yields.
    Badami KG; Sesun M; Basu A; Absalom N
    J Clin Apher; 2012 Nov; 27(5):247-54. PubMed ID: 22730096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
    Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
    Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. German multicenter studies on plateletpheresis from healthy donors. German Hemapheresis Study Group.
    Kretschmer V; Müller N; Godehardt E; Borberg H; Neumann HJ; Wesswange TG
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():125-9. PubMed ID: 8013969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
    Fontana S; Rados L; Schmid P; Leibundgut EO; Taleghani BM
    Transfusion; 2011 Sep; 51(9):2034-43. PubMed ID: 21438883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator.
    Chaudhary R; Das SS; Khetan D; Sinha P
    Transfus Apher Sci; 2006 Apr; 34(2):157-61. PubMed ID: 16510315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.
    Rahmani M; Fortin BM; Berliner N; Issa N; Neuberg D; Kaufman RM; Gansner JM
    Transfusion; 2019 May; 59(5):1644-1647. PubMed ID: 30747442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors.
    Sumner SM; Naskou MC; Thoresen M; Copland I; Peroni JF
    Transfusion; 2017 Jul; 57(7):1755-1762. PubMed ID: 28439897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-apheresis donor platelet count: an important platelet yield predictor.
    Saluja K; Thakral B; Sharma RR; Marwaha N
    J Clin Apher; 2006 Dec; 21(4):274. PubMed ID: 16847940
    [No Abstract]   [Full Text] [Related]  

  • 60. Apheresis affects bone and mineral metabolism.
    Amrein K; Katschnig C; Sipurzynski S; Stojakovic T; Lanzer G; Stach E; Pieber TR; Dobnig H
    Bone; 2010 Mar; 46(3):789-95. PubMed ID: 19922822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.